NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Stock Market Extends Losing Streak on Mixed Global Signals

The Indian stock market has extended its losing streak for a fourth consecutive session on Tuesday, May 12, amidst mixed global market signals. The benchmark indices, BSE Sensex and Nifty 50, witnessed significant declines, with the Sensex tumbling 1,566 points, or 2%, to hit an intraday low of 74,449. The Nifty 50 also slipped 2% to touch its day's low of 23,348.

By the close, the Sensex had settled 1,456 points, or 1.92%, lower at 74,559.24, while the Nifty 50 ended down 436 points, or 1.83%, at 23,379.55. The Bank Nifty index also witnessed weakness, opening with a gap-down at 54,178.40 and closing near the day's low at 53,555.20, declining by 884.70 points or 1.63% for the day.

Market Analysis

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

According to Sumeet Bagadia, Executive Director at Choice Broking, the formation of a strong bearish candlestick pattern on the daily timeframe reflects sustained selling pressure throughout the session and continued weakness in the broader market structure. From a technical perspective, immediate support for the Nifty 50 is placed in the 23,150-23,200 range, while resistance is observed between 23,550 and 23,600 levels.

IndexPrevious CloseCurrent CloseChange
Nifty 5023,816.0523,379.55-436.50
Bank Nifty54,440.9053,555.20-885.70

The Relative Strength Index (RSI) stands at 39.86 for the Nifty 50, slipping below the 40 mark and indicating weakening momentum with a bearish undertone. In the derivatives segment, notable call writing was seen at the 23,500 strike, followed by 23,600, while significant put writing was observed at 23,400 and 23,300 levels, indicating lower support zones with a broader bearish bias.

Stock Recommendations

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Despite the market's weakness, Sumeet Bagadia recommends five shares to buy on Wednesday, May 13:

1. R R Kabel

  • Buy at ₹1938, Target ₹2070, Stop Loss ₹1850
  • R R Kabel share price has entered a strong momentum phase after delivering a decisive breakout above its previous consolidation range and has surged into uncharted territory after registering a fresh all-time high.

2. V2 Retail

  • Buy at ₹220, Target ₹235, Stop Loss ₹210
  • V2 Retail share price is gradually gaining bullish traction after witnessing a steady recovery from its recent consolidation phase above 210 levels.

3. Bajaj Consumer Care

  • Buy at ₹547, Target ₹600, Stop Loss ₹520
  • Bajaj Consumer Care share price has entered a strong price discovery phase and is hovering near its record high zone around 547, highlighting sustained bullish momentum.

4. Onesource Specialty Pharma

  • Buy at ₹1830, Target ₹1950, Stop Loss ₹1740
  • Onesource Specialty Pharma share price is showing a strong recovery pattern and is currently trading around 1830 after a sharp rebound from lower levels.

5. Bliss GVS Pharma

  • Buy at ₹274, Target ₹300, Stop Loss ₹264
  • Bliss GVS Pharma share price is displaying impressive relative strength and is currently consolidating near its lifetime high zone around 274, indicating sustained bullish momentum.

These shares are expected to witness fresh momentum buying and may push their prices towards the target levels in the coming sessions.

Investor Takeaway

Investors should be cautious and consider selling stocks due to the ongoing market weakness.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.